Stockscreener 앱 받기
7.36
4.69%
0.33
시간 외 거래:
7.50
0.14
+1.90%
전일 마감가:
$7.03
열려 있는:
$6.96
하루 거래량:
42,525
Relative Volume:
0.36
시가총액:
$27.10M
수익:
-
순이익/손실:
$-31.11M
주가수익비율:
-4.8105
EPS:
-1.53
순현금흐름:
$-28.18M
1주 성능:
-1.74%
1개월 성능:
-1.08%
6개월 성능:
-35.40%
1년 성능:
-57.75%
1일 변동 폭
$6.96
$7.41
1주일 범위
$6.955
$7.54
52주 변동 폭
$5.3495
$28.34
Tempest Therapeutics Inc Stock (TPST) Company Profile
명칭
Tempest Therapeutics Inc
전화
415-798-8589
주소
2000 SIERRA POINT PARKWAY, BRISBANE
TPST을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TPST
Tempest Therapeutics Inc
|
7.36 | 26.03M | 0 | -31.11M | -28.18M | -1.53 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Tempest Therapeutics Inc Stock (TPST) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-10 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2025-04-10 | 다운그레이드 | Scotiabank | Sector Outperform → Sector Perform |
| 2024-03-14 | 개시 | Scotiabank | Sector Outperform |
| 2024-02-08 | 개시 | Jefferies | Buy |
Tempest Therapeutics Inc 주식(TPST)의 최신 뉴스
Real time alert setup for Tempest Therapeutics Inc. performanceInvestment Life Cycle Planning Summary - Newser
Why Tempest Therapeutics Inc. stock attracts strong analyst attentionFree Step-by-Step Trade Signal Implementation - Newser
Tempest Therapeutics Inc. stock chart pattern explainedSummary of Trade Cycles in 5-Year Range - Newser
What makes Tempest Therapeutics Inc. stock price move sharplySafe Momentum Strategy With Trend Analysis - Newser
Can machine learning forecast Tempest Therapeutics Inc. recoverySmart Stock Forecast Using AI Algorithms - Newser
Quantitative breakdown of Tempest Therapeutics Inc. recent moveSupport and Resistance Zone Summary Chart - Newser
Is it too late to sell Tempest Therapeutics Inc.Safe Momentum Strategy With Trend Analysis - Newser
Published on: 2025-08-10 01:25:41 - Newser
What technical models suggest about Tempest Therapeutics Inc.’s comeback - Newser
Multi factor analysis applied to Tempest Therapeutics Inc.Short Term Gain Strategy with AI Logic - Newser
Tempest Therapeutics Inc. Company’s Quarterly Earnings Growth: What the Numbers SayROI Focused Setup Screener With Exit Markers - Newser
Published on: 2025-08-09 23:28:19 - Newser
What data driven models say about Tempest Therapeutics Inc.’s futureBuy Signal Forecast With Short-Term Data - Newser
How Tempest Therapeutics Inc. stock performs during market volatilityFree Chart Breakout Buy Signal Detection - Newser
Tempest Therapeutics Inc. stock outlook for YEARReliable Setup Screener with Low Risk - Newser
Tempest Therapeutics Inc expected to post a loss of $2.60 a shareEarnings Preview - TradingView
Is Tempest Therapeutics Inc. stock bottoming outWeekly Hot Stocks Based on Volume Flow - Newser
Custom watchlist performance reports with Tempest Therapeutics Inc.Buy Candidate Summary Based on Fundamentals - Newser
Tempest Therapeutics (TPST) Expected to Announce Quarterly Earnings on Thursday - Defense World
Long term hold vs stop loss in Tempest Therapeutics Inc.Smart Forecast Signals from AI Models - Newser
Technical analysis overview for Tempest Therapeutics Inc. stockFree Buy Low Sell High Stock Watch - Newser
How Interest Rate Changes Impact Tempest Therapeutics Inc. Stock PerformanceAI Trading Forecast Based on Big Data - Newser
Morpheus-Liver Study: A New Horizon in Advanced Liver Cancer Treatment - TipRanks
What analysts say about Tempest Therapeutics Inc. stockCapitalize on market trends before they peak - Jammu Links News
Is it the right time to buy Tempest Therapeutics Inc. stockUnlock high-yield investment opportunities - Jammu Links News
Is Tempest Therapeutics Inc. stock overvalued or undervaluedAchieve consistent double-digit growth rates - Jammu Links News
Tempest Therapeutics Inc (TPST) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.24%
3.39%
자본화:
|
볼륨(24시간):